Boston Scientific To Participate In Morgan Stanley Global Healthcare Conference

MARLBOROUGH, Mass., Aug. 28, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2017 in New York City.

Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 30-minute question and answer session with the host analyst beginning at approximately 8:00 a.m. EDT.

A live webcast of the question and answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Emily Anderson

Susie Lisa, CFA

508-683-6305 (office)

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

Emily.Anderson2@bsci.com

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation

Top